3 days ago
MIRM
AnalystsMichael UlzMichael Ulz's Stock Forecasts
AnalystsMichael Ulz
Sectors:
Industries:
Analyst Ranking
Top 8%
#380 out of 5271 analysts
Average Return
+22.62%
Win Rate
56%52 out of 93
Risk vs Reward
Poor
Good
Michael Ulz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Kyverna Therapeutics IncKYTX | +335.86% | $1.98 | $8.63 | 2025-04-01 - 2026-03-31 | Strong Buy |
Silence Therapeutics PLCSLN | +310.96% | $5.29 | $21.74 | 2023-07-24 - 2024-07-23 | Strong Buy |
Alpine Immune Sciences IncALPN | +300.75% | $16.07 | $64.40 | 2023-11-03 - 2024-04-11 | Strong Buy |
Silence Therapeutics PLCSLN | +261.98% | $5.76 | $20.85 | 2023-06-12 - 2024-06-11 | Strong Buy |
Iveric Bio IncISEE | +255.14% | $11.19 | $39.74 | 2022-07-07 - 2023-07-06 | Strong Buy |
Michael Ulz Analyst Color
Get additional color on Michael Ulz's coverage of popular stocks
17 days ago
IONS
18 days ago
ARWR
5 months ago
DYN
5 months ago
MIRM
5 months ago
KYTX
6 months ago
IONS
7 months ago
VKTX
7 months ago
MIRM
7 months ago
IONS
8 months ago
IONS
a year ago
AKRO
2 years ago
DYN
2 years ago
THRD
2 years ago
SLN
2 years ago
MIRM
2 years ago
ALPN
Michael Ulz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mirum Pharmaceuticals IncMIRM | 7 | Strong Buy | $140.00 | +36.01% | Maintains | 3 days ago |
Ionis Pharmaceuticals IncIONS | 9 | Strong Buy | $130.00 | +72.30% | Maintains | 17 days ago |
Arrowhead Pharmaceuticals IncARWR | 8 | Strong Buy | $100.00 | +28.29% | Upgrades | 18 days ago |
Karyopharm Therapeutics IncKPTI | 9 | Buy | $15.00 | +69.49% | Maintains | a month ago |
Cabaletta Bio IncCABA | 7 | Strong Buy | $13.00 | +225.00% | Maintains | a month ago |
Dyne Therapeutics IncDYN | 4 | Strong Buy | $47.00 | +167.96% | Maintains | 2 months ago |
Aardvark Therapeutics IncAARD | 2 | Hold | $7.00 | +25.00% | Downgrades | 2 months ago |
Fractyl Health IncGUTS | 3 | Hold | $2.00 | +167.38% | Downgrades | 3 months ago |
Alnylam Pharmaceuticals IncALNY | 13 | Hold | $408.00 | +37.88% | Maintains | 3 months ago |
Kyverna Therapeutics IncKYTX | 3 | Strong Buy | $25.00 | +168.82% | Maintains | 5 months ago |
Viking Therapeutics IncVKTX | 4 | Strong Buy | $102.00 | +222.99% | Maintains | 7 months ago |
Silence Therapeutics PLCSLN | 12 | Strong Buy | $25.00 | +259.71% | Maintains | a year ago |
Y Mabs Therapeutics IncYMAB | 6 | Strong Sell | $7.00 | N/A | Maintains | a year ago |
Iovance Biotherapeutics IncIOVA | 4 | Buy | $20.00 | N/A | Maintains | a year ago |
Third Harmonic Bio IncTHRD | 5 | Hold | $5.00 | N/A | Downgrades | a year ago |
Akero Therapeutics IncAKRO | 4 | Strong Buy | $96.00 | N/A | Maintains | a year ago |
Blueprint Medicines CorpBPMC | 9 | Hold | $115.00 | N/A | Maintains | 2 years ago |
Alpine Immune Sciences IncALPN | 4 | Hold | $65.00 | N/A | Downgrades | 2 years ago |
Fate Therapeutics IncFATE | 7 | Hold | $7.00 | N/A | Maintains | 2 years ago |
Kalaris Therapeutics IncKLRS | 4 | Strong Sell | $11.50 | N/A | Downgrades | 2 years ago |
Oric Pharmaceuticals IncORIC | 2 | Buy | $27.00 | N/A | Maintains | 3 years ago |
Mirati Therapeutics IncMRTX | 8 | Hold | $37.00 | N/A | Maintains | 3 years ago |
Iveric Bio IncISEE | 3 | Strong Buy | $35.00 | N/A | Maintains | 3 years ago |
Senti Biosciences IncSNTI | 3 | Hold | $20.00 | N/A | Maintains | 3 years ago |
Rocket Pharmaceuticals IncRCKT | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 3 years ago |
Xilio Therapeutics IncXLO | 3 | Strong Buy | $140.00 | N/A | Maintains | 3 years ago |
Allakos IncALLK | 4 | Hold | $8.00 | N/A | Maintains | 3 years ago |
Taysha Gene Therapies IncTSHA | 1 | Hold | $3.00 | N/A | Downgrades | 3 years ago |
Vir Biotechnology IncVIR | 1 | Hold | $30.00 | N/A | Upgrades | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 2 | Strong Buy | $90.00 | N/A | Maintains | 4 years ago |
Jounce Therapeutics IncJNCE | 3 | Hold | $7.00 | N/A | Downgrades | 4 years ago |
Tectonic Therapeutic IncTECX | 2 | Hold | $36.00 | N/A | Maintains | 4 years ago |
Igm Biosciences IncIGMS | 2 | Hold | $38.00 | N/A | Downgrades | 4 years ago |
Iteos Therapeutics IncITOS | 1 | Buy | $45.00 | N/A | Initiates Coverage On | 6 years ago |
Neurogene IncNGNE | 1 | Buy | $125.00 | N/A | Initiates Coverage On | 6 years ago |
Mersana Therapeutics IncMRSN | 2 | Buy | $500.00 | N/A | Maintains | 6 years ago |
Atreca IncBCEL | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 6 years ago |
Merrimack Pharmaceuticals IncMACK | 2 | Hold | $4.00 | N/A | Maintains | 8 years ago |
Aceragen IncACGN | 1 | Buy | $4.00 | N/A | Maintains | 8 years ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Buy | $80.00 | N/A | Maintains | 9 years ago |
Amicus Therapeutics IncFOLD | 2 | Buy | $15.00 | N/A | Maintains | 9 years ago |
Tesaro IncTSRO | 1 | Hold | $182.00 | N/A | Downgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.